Skip to content
Checked.be
Complete company report
Generated 12-08-2026
Active BE 0666.961.607Public limited company

Aphea.Bio

Technologiepark-Zwijnaarde 21 ·9052 Gent, Belgium· 9 yrs active
Sector: Speur- en ontwikkelingswerk op biotechnologisch gebied (72101)
Conclusion Checked

The computed 12-month bankruptcy probability of Aphea.Bio is 0.3% (very low). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 9 yrs
Board 14
Locations 1
Publications 20
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
More than 3 years active
Founded in 2016, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags 0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview8 NBB filings
Financials being processed
NBB has 8 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 20-06-2025 2025-00157890
31-12-2023 verkort 18-07-2024 2024-00256683
31-12-2022 verkort 20-07-2023 2023-00253383
31-12-2021 verkort 04-07-2022 2022-20131834
31-12-2020 verkort 03-06-2021 2021-17500210
31-12-2019 verkort 10-07-2020 2020-29400376
31-12-2018 verkort 23-05-2019 2019-14100581
31-12-2017 verkort 08-05-2018 2018-12400202
Directors & mandates 21 directors
Current directors & mandates
  • Hartmut van Lengerich
    Director
    State Gazette act 25162903 (29-12-2025)
    Current
    27-11-2025 → present
  • Stéphane Roussel
    Director
    State Gazette act 25162903 (29-12-2025)
    Current
    27-11-2025 → present
    2 events
    • 27-11-2025 Appointed· Director
    • 31-07-2023 Resigned· Director
  • Hendrik Van Asbroeck
    Director
    State Gazette act 25162903 (29-12-2025)
    Current
    21-05-2025 → present
    2 events
    • 21-05-2025 Appointed· Director
    • 31-07-2023 Resigned· Director
  • Isabelle Laurencin
    Director
    State Gazette act 25162903 (29-12-2025)
    Current
    21-05-2025 → present
  • Laetitia de Panafieu
    Director
    State Gazette act 24158725 (06-11-2024)
    Current
    17-04-2024 → present
  • Agri Investment Fund NVLegal entity
    Director· perm. rep.: Patrik Louis Haesen
    State Gazette act 23377035 (31-07-2023)
    Current
    31-07-2023 → present
  • Hendrik Kamiel Van Asbroeck
    Director
    State Gazette act 23377035 (31-07-2023)
    Current
    31-07-2023 → present
  • Innovation Industries Management III B.V.Legal entity
    Director· perm. rep.: Caaj Douwe Greebe
    State Gazette act 23377035 (31-07-2023)
    Current
    31-07-2023 → present
  • KORYS MANAGEMENT
    Director
    State Gazette act 23377035 (31-07-2023)
    Current
    31-07-2023 → present
  • Isabel Julia VERCAUTEREN
    Managing director
    State Gazette act 23377035 (31-07-2023)
    Current
    20-07-2023 → present
  • Agri Investment FundLegal entity
    Director· perm. rep.: Patrik Haesen
    State Gazette act 21152639 (29-12-2021)
    Current
    30-09-2021 → present
  • Stéphane René Pierre Roussel
    Director
    State Gazette act 23377035 (31-07-2023)
    Current
    16-10-2020 → present
    2 events
    • 31-07-2023 Appointed· Director
    • 16-10-2020 Appointed· Director
  • VERCAUTEREN Isabel Julia René
    Managing director
    State Gazette act 20350899 (23-10-2020)
    Current
    16-10-2020 → present
  • Participatiemaatschappij VlaanderenLegal entity
    Director· perm. rep.: Thomas Beke
    State Gazette act 20112853 (29-09-2020)
    Current
    31-03-2020 → present
Former directors (7)
  • Hadyn Parry
    Director
    State Gazette act 24021292 (02-02-2024)
    Former
    02-02-2024 → 07-01-2026
    2 events
    • 07-01-2026 Resigned· Director
    • 02-02-2024 Appointed· Director
  • Johan De Saegher
    Director
    State Gazette act 24021292 (02-02-2024)
    Former
    - → 02-02-2024
    2 events
    • 02-02-2024 Resigned· Director
    • 31-07-2023 Resigned· Director
  • Agri Investment Fund BVLegal entity
    Director· perm. rep.: Patrik Haesen
    State Gazette act 23377035 (31-07-2023)
    Former
    - → 31-07-2023
  • Isabel Vercauteren
    Director
    State Gazette act 23377035 (31-07-2023)
    Former
    - → 31-07-2023
  • Johan Cardoen
    Director
    State Gazette act 23377035 (31-07-2023)
    Former
    - → 31-07-2023
  • NV PMVLegal entity
    Director· perm. rep.: Thomas Beke
    State Gazette act 23377035 (31-07-2023)
    Former
    - → 31-07-2023
  • Willem Broeckaert
    Director
    State Gazette act 23377035 (31-07-2023)
    Former
    - → 31-07-2023
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor 3 auditor
Statutory auditor IRE/IBR number Tenure
BDO Bedrijfsrevisoren bvCurrent
Company auditor · represented by Veerle Catry
 - 20-07-2023 → present
BDO Bedrijfsrevisoren
Company auditor · represented by Veerle Catry
succeeded by BDO Bedrijfsrevisoren CVBA in 2020
 - 29-06-2017 → 29-09-2020
BDO Bedrijfsrevisoren CVBA
Company auditor · represented by Veerle Catry
succeeded by BDO Bedrijfsrevisoren bv in 2023
 - 29-09-2020 → 20-07-2023
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Speur- en ontwikkelingswerk op biotechnologisch gebied(72101)
Legal form Public limited company(014)
Incorporation05-12-2016
StatusActive
Postal code9052
Connections & network 48 connected companies
Group structure
Agri Investment Fund
Sits on the board · 3 subsidiaries · 1 location
Control→
Participatiemaatschappij Vlaanderen
Sits on the board · 45 subsidiaries · 1 location
Control→
FBM
We sit on their board · 1 location
→
Network connections
Aelin Therapeutics
Shared corporate director
→
AnimAb
Shared corporate director
→
Arts Gebroeders immobilière
Shared corporate director
→
Belgian Offshore Platform
Shared corporate director
→
BELWIND
Shared corporate director
→
Biotalys
Shared corporate director
→
BLUE GATE ANTWERP PUBLIC HOLDING
Shared corporate director
→
CITYMESH INTEGRATOR
Shared corporate director
→
Confo Therapeutics
Shared corporate director
→
CONTENTO
Shared corporate director
→
DBFM Scholen van Morgen
Shared corporate director
→
FEops
Shared corporate director
→
GIGARANT
Shared corporate director
→
Hexagon Invest
Shared corporate director
→
HEXAGON INVEST II
Shared corporate director
→
HOF van LORREINEN
Shared corporate director
→
Hubspot Belgium
Shared corporate director
→
iFLUX
Shared corporate director
→
Indigo Diabetes
Shared corporate director
→
Inmanta
Shared corporate director
→
INNOVATION FUND
Shared corporate director
→
InOpSys
Shared corporate director
→
InvestSuite
Shared corporate director
→
LINEAS GROUP
Shared corporate director
→
MyCartis
Shared corporate director
→
PANQUIN CONSTRUCT
Shared corporate director
→
PANQUIN LAND
Shared corporate director
→
Plopsa Station Antwerp
Shared corporate director
→
PMV - Standaardleningen
Shared corporate director
→
PROMAN Agilitas
Shared corporate director
→
QustomDot
Shared corporate director
→
REIN4CED
Shared corporate director
→
RENEWABLE ENERGY BASE OSTEND
Shared corporate director
→
ReWind Therapeutics
Shared corporate director
→
RheaVita
Shared corporate director
→
SCHOOL INVEST
Shared corporate director
→
ST Engineering iDirect (Europe) CY
Shared corporate director
→
→
SupplyStack
Shared corporate director
→
THE BELGIAN CHOCOLATE EXPERIENCE
Shared corporate director
→
The Fourth Law
Shared corporate director
→
TRENDMINER
Shared corporate director
→
Vlaams Energiebedrijf
Shared corporate director
→
WANDELAAR INVEST
Shared corporate director
→
XFA
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control 3 parties
Control over this companysits on this company's board2
Participatiemaatschappij Vlaanderen
45 subsidiaries · 1 location
Agri Investment Fund
3 subsidiaries · 1 location
controls
Aphea.BioBE 0666.961.607
controls
Where this company holds controlthis company sits on their board1
FBM
1 location

Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.

Establishment units 1 location
Aphea.Bio
Technologiepark-Zwijnaarde 21, 9052 GentVervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw
since 20162.259.481.970
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44082B0040/00C000 Flanders 8,776 m² 1 · 2,491 m² 29.1 m · 8 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 28 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
30-03-2026
State Gazette act Resignations & appointments
General meeting · Director resignation · Power of attorney
2025
20-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
18-07-2024
NBB filing Annual accounts filed
fiscal year 2023 · verkort
2023
20-07-2023
NBB filing Annual accounts filed
fiscal year 2022 · verkort
2022
04-07-2022
NBB filing Annual accounts filed
fiscal year 2021 · verkort
2021
03-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · verkort
2020
10-07-2020
NBB filing Annual accounts filed
fiscal year 2019 · verkort
2019
23-05-2019
NBB filing Annual accounts filed
fiscal year 2018 · verkort
2018
08-05-2018
NBB filing Annual accounts filed
fiscal year 2017 · verkort
Belgisch Staatsblad, acts 20 acts
Capital history · 6
28-02-2024
v3.2
31-07-2023
v3.2
12-01-2022
v3.2
17-06-2021
v3.2
17-06-2021
v3.2
29-05-2019
v3.2
All acts · 20 updated 4 months ago
2026
30-03-2026 Hadyn Parry resigns as director Director changes
  • Hadyn Parry, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hadyn Parry",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO"
  }
}
2025
29-12-2025 4 directors appointed Director changes
  • Hendrik Van Asbroeck, Bestuurder
  • Isabelle Laurencin, Bestuurder
  • Hartmut van Lengerich, Bestuurder
  • Stéphane Roussel, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hendrik Van Asbroeck",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-05-21",
      "evidence_quote": "De algemene vergadering benoemt vervolgens, met onmiddellijke ingang en voor een periode van 6 jaar, (i) Hendrik Van Asbroeck en (ii) Isabelle Laurencin tot bestuurders van de Vennootschap."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Isabelle Laurencin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-05-21",
      "evidence_quote": "De algemene vergadering benoemt vervolgens, met onmiddellijke ingang en voor een periode van 6 jaar, (i) Hendrik Van Asbroeck en (ii) Isabelle Laurencin tot bestuurders van de Vennootschap."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hartmut van Lengerich",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-11-27",
      "evidence_quote": "De algemene vergadering benoemt vervolgens, met onmiddellijke ingang en voor een periode van 6 jaar, (i) Hartmut van Lengerich en (ii) St\u00E9phane Roussel tot bestuurders van de Vennootschap."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "St\u00E9phane Roussel",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2025-11-27",
      "evidence_quote": "De algemene vergadering benoemt vervolgens, met onmiddellijke ingang en voor een periode van 6 jaar, (i) Hartmut van Lengerich en (ii) St\u00E9phane Roussel tot bestuurders van de Vennootschap."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2024
06-11-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-04-17",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  },
  "signature_regime": "solo",
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
12-07-2024 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2024-06-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}
28-02-2024 Capital increase of €208,333.50 to €28,621,976.82 Capital & shares
  • €28.413.643,32 → €28.621.976,82
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 208333.5,
      "currency": "EUR",
      "after_eur": 28621976.82,
      "delta_eur": 208333.5,
      "before_eur": 28413643.32,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-01-31",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 208.333,50 EUR om het te brengen van 28.413.643,32 EUR op 28.621.976,82 EUR, door een inbreng in geld",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
02-02-2024 2 directors appointed, 1 resigning Director changes
  • Deloitte Bedrijfsrevisoren BV, Commissaris
  • Hadyn Parry, Bestuurder
  • Johan De Saegher, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Deloitte Bedrijfsrevisoren BV",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-08-01",
      "evidence_quote": "De algemene vergadering beslist om \u0022Deloitte Bedrijfsrevisoren BV\u0022, met zetel te 1930 Zaventem, Luchthaver Brussel Nationaal 1 J, Gateway Building, ingeschreven bij de Kruispuntbar\u0131k var Onderneminigen onder het nummer 0429.053.863, met ingang van 1 augustus 2023 te benoemen tot commissaris van de v"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Johan De Saegher",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De algemere vergadering neemt hierbij kennis var het ontslag van de heer Johan De Saegher als bestuurder var\u0131 de Vennootschap en dit met onmiddellijke ingang."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Hadyn Parry",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De algemene vergadering benoemt vervolgens, met onmiddellijke ingang en voor een periode van 6 jaar, de heer Hadyn Parry tot bestuurder var\u0131 de Vennootschap."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2023
31-07-2023 Capital increase of €20,052,539.80 to €41,189,792.15 Capital & shares
  • €21.137.252,35 → €41.189.792,15
  • 3 kapitaalbewegingen in deze akte
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 3072460.2,
      "currency": "EUR",
      "after_eur": 21137252.35,
      "delta_eur": 3072460.2,
      "before_eur": 18064792.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-07-20",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen in natura ten belope van EUR 3.072.460,20, om het kapitaal te brengen van EUR 18.064.792,15 op EUR 21.137.252,35",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 20052539.8,
      "currency": "EUR",
      "after_eur": 41189792.15,
      "delta_eur": 20052539.8,
      "before_eur": 21137252.35,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-07-20",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van EUR 20.052.539,80, om het te brengen van EUR 21.137.252,35 op EUR 41.189.792,15, door een inbreng in geld",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_decrease",
      "amount": 12776148.83,
      "currency": "EUR",
      "after_eur": 28413643.32,
      "delta_eur": -12776148.83,
      "before_eur": 41189792.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-07-20",
      "evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, ... te verminderen ten belope van EUR 12.776.148,83, om het te brengen van EUR 41.189.792,15 op EUR 28.413.643,32",
      "contribution_type": null
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
23-01-2023 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Tim CARNEWAL
Summary: otherNotary: Tim CARNEWAL · BrusselFirm: BERQUIN NOTARISSEN
Technical details 
{
  "stage": null,
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTARISSEN",
    "office_city": "Brussel",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2023-01-23",
    "filing_date": "2023-01-19",
    "act_kind_objet": "DIVERSEN"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2022-06-27",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": null,
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "Aphea.Bio",
    "legal_form": "Naamloze vennootschap"
  },
  "detected_kind_raw": "material_correction",
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "summary_narrative": "De akte van 27 juni 2022 bevatte een materi\u00EBle fout in de vermelding van de samenstelling van de algemene vergadering van Aphea.Bio. De correctie betreft de vermelding van drie aandeelhouders, waarvan twee Luxemburgse vennootschappen en \u00E9\u00E9n Vlaamse vennootschap, met hun aandelenbezit. De correctie werd gepubliceerd in de Bijlagen bij het Belgisch Staatsblad op 23 januari 2023.",
  "co_filed_documents": [
    "een uitgifte van de akte"
  ],
  "detected_real_type": "other",
  "referenced_correction": {
    "prior_pub_date": "2022-07-05",
    "what_corrected": "de samenstelling van de vergadering (aandeelhouders) in de akte van 27 juni 2022",
    "prior_pub_number": "22343568"
  },
  "should_reroute_to_category": null
}
2022
05-07-2022 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2022-06-27",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "De vergadering verleent bijzondere volmacht aan BAERT Fien en alle andere advocaten en medewerkers van het kantoor \u0022Deloitte Legal\u0022 met zetel te 9051 Gent, Raymonde de Larochelaan 19/B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "BAERT Fien",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "De vergadering verleent bijzondere volmacht aan BAERT Fien en alle andere advocaten en medewerkers van het kantoor \u0022Deloitte Legal\u0022 met zetel te 9051 Gent, Raymonde de Larochelaan 19/B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
      "holder_kbo": null,
      "holder_name": "Deloitte Legal",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}
12-01-2022 Capital increase of €11,277,400 to €18,064,792.15 Capital & shares
  • €6.787.392,15 → €18.064.792,15
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 11277400.0,
      "currency": "EUR",
      "after_eur": 18064792.15,
      "delta_eur": 11277400.0,
      "before_eur": 6787392.15,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-12-20",
      "evidence_quote": "De vergadering beslist om het kapitaal van de Vennootschap te verhogen met een bedrag van elf miljoen tweehonderdzevenenzeventigduizend vierhonderd euro (EUR 11.277.400,00) om het te brengen van zes miljoen zevenhonderdzevenentachtigduizend driehonderdtwee\u00EBnnegentig euro vijftien cent (EUR 6.787.392,15) op achttien miljoen vierenzestigduizend zevenhonderdtwee\u00EBnnegentig euro vijftien cent (EUR 18.064.792,15) door uitgifte van negen miljoen driehonderdzevenennegentigduizend achthonderd\u00E9\u00E9nendertig (9.397.831) nieuwe Bevoorrechte B Aandelen zonder vermelding van waarde, met onmiddellijke ingenottreding.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2021
29-12-2021 Patrik Haesen appointed as director Director changes
  • Patrik Haesen, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patrik Haesen",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0893885781",
        "name": "AIF",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-09-30",
      "evidence_quote": "besluit unaniem om (door middel van co\u00F6ptatie) AIF, permanent vertegenwoordigd door de heer Patrik Haesen, met zetel te Diestsevest 32/5b, 3000 Leuven, met ondernemingsnummer 0893.885.781, als nieuwe bestuurder van de Vennootschap te benoemen, met ingang van 30 september 2021"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
17-06-2021 Capital increase of €500,000 to €6,780,159.75 Capital & shares
  • €6.280.159,75 → €6.780.159,75
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 500000,
      "currency": "EUR",
      "after_eur": 6780159.75,
      "delta_eur": 500000.0,
      "before_eur": 6280159.75,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-06-04",
      "evidence_quote": "De vergadering beslist om het kapitaal van de Vennootschap te verhogen met een bedrag van vijfhonderdduizend euro (EUR 500.000) om het te brengen van zes miljoen tweehonderdtachtigduizend honderdnegenenvijftig euro vijfenzeventig cent (EUR 6.280.159,75) op zes miljoen zevenhonderdtachtigduizend honderdnegenenvijftig euro vijfenzeventig cent (EUR 6.780.159,75) door uitgifte van vierhonderdzestienduizend zeshonderdzesenzestig (416.666) nieuwe Bevoorrechte B Aandelen zonder vermelding van waarde, met onmiddellijke ingenottreding.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
17-06-2021 Capital increase of €7,232.40 to €6,787,392.15 Capital & shares
  • €6.780.159,75 → €6.787.392,15
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 7232.4,
      "currency": "EUR",
      "after_eur": 6787392.15,
      "delta_eur": 7232.4,
      "before_eur": 6780159.75,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2021-06-04",
      "evidence_quote": "Het kapitaal werd verhoogd met 7.232,40 EUR, en gebracht van 6.780.159,75 EUR op 6.787.392,15 EUR.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
13-04-2021 ROUSSEL Stéphane René Pierre appointed as director Director changes
  • ROUSSEL Stéphane René Pierre, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "ROUSSEL St\u00E9phane Ren\u00E9 Pierre",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2020-10-16",
      "evidence_quote": "B. De vergadering beslist te benoemen tot bestuurder met ingang van 16 oktober 2020: - Als Nieuwe Investeerder Bestuurder: o De heer ROUSSEL St\u00E9phane Ren\u00E9 Pierre, woonstkeuze doend op de zetel van de Vennootschap."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2020
23-10-2020 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2020-10-16",
    "legal_form_change": false
  },
  "bedrijfsrevisor": {
    "quote": "Conclusies van het verslag van de commissaris de dato vijftien oktober 2020, opgesteld door de co\u00F6peratieve vennootschap met beperkte aansprakelijkheid BDO Bedrijfsrevisoren CVBA, vertegenwoordigd door de heer Veerle Catry, bedrijfsrevisor",
    "firm_kbo": null,
    "firm_name": "BDO Bedrijfsrevisoren CVBA",
    "ibr_number": null,
    "individual_name": "Veerle Catry"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "De vergadering verleent een bijzondere volmacht aan iedere bestuurder van de Vennootschap en aan iedere advocaat van het kantoor Deloitte Legal - Lawyers CVBA, met zetel te Gateway Building, Luchthaven Nationaal 1J, 1932 Zaventem, afzonderlijk handelend, tot het actualiseren van het aandelen- en warrantenregister teneinde deze in overeenstemming te brengen met de genomen beslissingen.",
      "holder_kbo": null,
      "holder_name": "Deloitte Legal - Lawyers CVBA",
      "scope_categories": [
        "share_register_update",
        "warrant_register_update",
        "filing_formalities"
      ],
      "with_substitution": false
    }
  ],
  "governance_change": {
    "admin_delegated_added": [
      {
        "name": "VERCAUTEREN Isabel Julia Ren\u00E9",
        "quote": "De Raad van Bestuur kan het dagelijks bestuur van de Vennootschap opdragen aan \u00E9\u00E9n of meerdere personen, al dan niet Bestuurders (de Gedelegeerd Bestuurder of CEO). ... - Als CEO: o Mevrouw VERCAUTEREN Isabel Julia Ren\u00E9, wonende te 9550 Herzele, Hellestraat 1, woonstkeuze doend op de zetel van de Vennootschap.",
        "excluded_powers": null
      }
    ]
  }
}
29-09-2020 1 director appointed, 1 reappointed Director changes
  • Thomas Beke, Bestuurder
  • Veerle Catry, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas Beke",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0455777660",
        "name": "ParticipatieMaatschappij Vlaanderen NV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2020-03-31",
      "evidence_quote": "De algemene vergadering beslist dat ... ParticipatieMaatschappij Vlaanderen NV, permanent vertegenwoordigd door de heer Thomas Beke, met zetel te Oude Graanmarkt 63, 1000 Brussel, met ondernemingsnummer 0455.777.660, als nieuwe bestuurder van de vennootschap te benoemen, met ingang van 31 maart 2020"
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Veerle Catry",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BDO Bedrijfsrevisoren CVBA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering beslist dat de vennootschap die de vorm van een co\u00F6peratieve vennootschap met beperkte aansprakelijkheid heeft aangenomen, \u0022BDO Bedrijfsrevisoren\u0022 gevestigd te 1935 Zaventem, DA Vincilaan 9/E 6, te herbenoemen tot commissaris van de vennootschap en dit tot de algemene vergade"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
22-04-2020 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2019
29-05-2019 Capital decrease of €3,975,000 to €5,100,000 Capital & shares
  • €9.075.000 → €5.100.000
  • 2 kapitaalbewegingen in deze akte
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 2958000.0,
      "currency": "EUR",
      "after_eur": 9075000.0,
      "delta_eur": 2958000.0,
      "before_eur": 6117000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-03-29",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen met twee miljoen: negenhonderdachtenvijftigduizend euro (\u20AC 2.958.000,00), om het te brengen van zes miljoen; honderdzeventienduizend euro (\u20AC 6.117.000,00) op negen miljoen vijfenzeventigduizend euro (\u20AC 9.075.000,00).",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_decrease",
      "amount": 3975000.0,
      "currency": "EUR",
      "after_eur": 5100000.0,
      "delta_eur": -3975000.0,
      "before_eur": 9075000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2019-03-29",
      "evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verminderen met enerzijds een bedrag van drie miljoen vierhonderd twee\u00EBntachtig duizend honderd drie\u00EBndertig euro en eenentachtig eurocent (\u20AC 3.482.133,81) ter aanzuivering van overgedragen verliezen per laatste balansdatum, zijnde per 31 december 2018, met het oog op het herstel van het eigen vermogen van de Vennootschap, en anderzijds ter aanleg van een reserve ten belope van vierhonderd twee\u00EBnnegentig duizend achthonderd zesenzestig euro en negentien eurocent (\u20AC 492.866,19) ter dekking van voorzienbare verliezen, teneinde het te brengen van negen miljoen vijfenzeventigduizend euro (\u20AC 9.075.000,00) op vijf miljoen honderdduizend euro (\u20AC 5.100.000)",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2017
10-07-2017 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "APHEA.BIO",
    "legal_form": "NV"
  }
}
2016
07-12-2016 Incorporation of a new NV Incorporation
Summary: oprichting
Technical details 
{
  "kind": "oprichting",
  "seat": "Rijvisschestraat 120, 9052 Gent",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": null,
        "name": "V-Bio Ventures Fund 1 ARKIV"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "B",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "V-Bio Ventures Fund 1 ARKIV",
      "contribution_type": "cash",
      "amount_paid_in_eur": 140000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 140000,
      "amount_subscribed_eur": 140000,
      "is_anonymous_silent_partner": false
    },
    {
      "org": {
        "kbo": null,
        "name": "VIB"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "A",
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": "VIB",
      "contribution_type": "in_kind",
      "amount_paid_in_eur": 240000,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 240000,
      "amount_subscribed_eur": 240000,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 380000,
  "subject_company": {
    "kbo": "0666.961.607",
    "name_full": "Aphea.Bio",
    "legal_form": "NV"
  },
  "initial_directors": [],
  "incorporation_date": "2016-12-05",
  "post_incorporation_mandates": []
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110Vervaardiging van verdelgingsmiddelen en van andere chemische producten voor de landbouw20200Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw20200
Primary activity highlighted.
Names & trade names
Legal nameNL Aphea.Bio
Registered office
Technologiepark-Zwijnaarde 21
9052 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 143 of 760 with filed accounts
ABLYNX BE 0475.295.446 · Gent
ADx NeuroSciences BE 0839.400.980 · Gent
AmphiStar BE 0771.868.491 · Gent
argenx BE 0818.292.196 · Gent
Benebiose BE 0784.521.548 · Gent
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative